MedTrace Logo

Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication

NCT02436200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-09-29

Study results available
· View outcomes & findings →

Summary

This study will assess the benefit of a neuromuscular electrical stimulation device in patients suffering from symptoms and effects of lower limb intermittent claudication.

Conditions

  • Intermittent Claudication
  • Peripheral Vascular Disease

Interventions

DEVICE

Neuromuscular Electrical Stimulation

Revitive IX neuromuscular electrical stimulation device will be given to all participants as per protocol.

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alun H Davies, BA BMChB MA · Imperial College London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02436200 on ClinicalTrials.gov